Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Oral Oncology|July 27, 2019
ATR inhibition sensitizes HPV- and HPV+ head and neck squamous cell carcinoma to cisplatinBrandon C Leonard, Eliot D Lee, Neil E Bhola, et al.
Biomedical Chromatography : BMC|June 9, 2025
Quantitation of Tuvusertib (M1774) in Human Plasma by LC-MS/MSTien V Le, Robert A Parise, Julianne L Holleran, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 19, 2019
An ATR and CHK1 kinase signaling mechanism that limits origin firing during unperturbed DNA replicationTatiana N Moiseeva, Yandong Yin, Michael J Calderon, et al.
JCI Insight|December 22, 2020
Syngeneic tobacco carcinogen-induced mouse lung adenocarcinoma model exhibits PD-L1 expression and high tumor mutational burdenLaura P Stabile, Vinod Kumar, Autumn Gaither-Davis, et al.
JCI Insight|February 22, 2023
The schedule of ATR inhibitor AZD6738 can potentiate or abolish antitumor immune responses to radiotherapyFrank P Vendetti, Pinakin Pandya, David A Clump, et al.
Toxicology and Applied Pharmacology|May 8, 2025
Comparative in vivo toxicology of ATR inhibitors ceralasertib, elimusertib, and berzosertib alone and in combination with ionizing radiationJoshua J Deppas, Brian F Kiesel, Jianxia Guo, et al.
Journal of Proteome Research|August 23, 2012
Quantitative proteomics reveal ATM kinase-dependent exchange in DNA damage response complexesSerah Choi, Rohith Srivas, Katherine Y Fu, et al.
Pageof 9